George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Very nice premium. Would be nice if another bidder smoked out but can't see it. Juicy premium. Very happy and time to poke out something else.
impossible to time it. trades between 7.50 and 8.4 and as soon as it gets to 8.4 falls back down again then up again then down again - head wrecking.
Good point Egg. Well I will add UDG to my regular investments and see if i can find troughs. Given te numbers today I reckon a 5% rise is an injustice and that 10% to 850p would be fairer. My initial TP is 850p therefore and I am a buyer up to 835p for now.
It has tested current levels mid 820's a few times but failed to break higher & retreated to 760s. Maybe this time. Solid company and should see steady rise from here this time hopefully.
I cant understand why tis share is so off-radar. Today's update is sparkling and prompts me to add more. Very sound results and a good basis for more gains going forward. Hardly any posters here either which is usually a positive.
UDG Healthcare...........
Interesting to see the forward forecast for the company.
As per the majority of stock it will take a (very small) hit for 30/09/2020 but then in 2021 bounces back with vengeance, with a 16% rise in EPS which would put it on a p/e of 17 and a PEG of 1........in other words a (late) Jim Slater ZULU principle stock.
SEE forward forecasts below.
FORECAST
year Ending Revenue
(€m) Pre-tax(€m) EPS P/E PEG EPS Growth Div Yield
2020-09-30 1,005.48 102.04 36.88p 20.1 -4.8 -4% 11.18p 1.5%
2021-09-30 1,087.20 122.83 42.91p 17.1 1.0 16% 15.01p 2.0%
CHART
SP as moved above the 200 day moving average a bullish sign. In a lovely uptrend.
https://uk.advfn.com/p.php?pid=legacydaily&epic=L^UDG&type=4&size=3&period=4&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES
UDG...........
UDG Healthcare PLC UDG Peel Hunt Buy 732.00 744.00 1,165.00 - Reiterates SP Target 1,165p
UDG Healthcare PLC UDG Barclays Capital Overweight 732.00 744.00 910.00 875.00 Reiterates SP target 875p
UDG Broker Forecasts..........
Latest broker views
Date Broker Recomm. Current Price Price when issued Old price New price
22 May 20 Berenberg Buy 692.50 694.00 740.00 880.00
19 May 20 Liberum Capital Buy 692.50 623.50 900.00 -
19 May 20 Peel Hunt Buy 692.50 623.50 1,165.00
UDG Healthcare UDG.. worth a bob or two investment.
UDG valuation is ‘compelling’, says Berenberg
Healthcare packaging company UDG Healthcare (UDG) is trading on a ‘compelling valuation’ for a market leader, says Berenberg.
Analyst Eoghan Read retained his ‘buy’ recommendation and increased his target price from 740p to 880p. The shares rose 1.6% to 692.5p yesterday.
First-half results from the group beat Read’s forecasts by 6% and he said while it had not been immune from the impact of Covid-19, his ‘confidence in the equity story’ had increased thanks to positive momentum, operating resilience, and the ‘long-term structural drivers evident in the market’.
‘UDG remains one of our top picks in our UK mid-cap business services coverage,’ he said. ‘Trading on a 20% discount to long-term average and US peers, we think it now presents a compelling valuation opportunity for a structurally growing and market-leading operator.’
============================================================================
Lovely uptrend channel on the chart. If it breaks through the ceiling of the channel, next sp target mid term is 730p approx. P/E 19 for 2021, cheap considering the Boom in Bios and health at the moment.
https://content.screencast.com/users/thomaser/folders/Default/media/0e47ae5a-0696-4dc2-bb41-b0f48b3b76a4/udg%202.jpg
With gains building on yesterday's rise. UDG looking in rude health once more. Results were at the top end of guidance so after 18 months of ill-health I am looking forward to the dizzy heights of 900p again.
A much more favourable response his morning after a consideration of the results has taken place.. A 6.07% increase is a good antidote to yesterday's sickly sell-off. The outlook was fairly confident so I am hoping we can breach 800p and move back towards highs.
and no real headaches. 5% rise in the divi to 12.5p is surely not to be sneezed at. I expect the SP to be perkier this morning and with the reasonably confident outlook I am hoping the SP gets off its sick bed and reaches 800p again. Might be a stretcher to say today but in the course of time.
Not looking great for this share now with the BOD selling £362k and now an ii reducing their holding. The price hovering around the broker target, RSI high and STOCK over bought.
Thanks for the info. I'm new to the game and just feeling my way.
Hi, yes.
Hi, just a question as I'm not sure. Will you still be paid a dividend now you've sold them as you still owned them on Ex divi date? Thanks
Well I was going to keep these a bit longer, but I had forgotten I had set a sell up for 750p.
Still a nice profit and gla who are holding. 800p looks a strong possibility.
http://www.chartupload.com/viewer.php?file=85235482156202550277.png
Pull back in the last 2 days where it seems to be bouncing of support (previous resistance). Could we see a blue day today on a FTSE down day?
Another pattern formed, the Bullish Round Bottom, which if plays out correctly should see UDG knocking on 800p, the broker target.
Great update today and hopefully positioned to make progress from here. The fall from 900p to 585p was totally unwarranted so UDG is probably still good value even after a rise today. A hold above 700p by close would be useful if that could be established as a floor here. With the dollar strengthening it will be useful income and a hedge against the Euro and Pound with a good RoR in three years. I am looking to add more here.
Resistance broken withe the news received today. 750p on its way but I may now have to change my target to next resistance of 800p.
670p target hit. If it can break above the resistance, then next target will be 750p where I'm looking to sell at.
Good to see the share price pass the resistance at 616, retrace and bounce of that resistance that should now become support. Next target price of 670p.
in Shares Magazine today. A 40% fall in the SP is surely unwarranted. A long road back but I certainly think the fall is overdone.
Looks like a BOD took note of the IC buy and added £44k at £5.87
Those who kept the faith in UDG Healthcare (UDG) have been duly rewarded following a better-than-expected first-quarter update from the medical services group. Having "made a good start to the financial year", the group says pre-tax profits are currently tracking "well ahead" of the prior year, driven by a combination of good underlying growth and contributions from acquisitions made in 2018.
UDG:LSE
UDG Healthcare PLC
1mth
Today change
0.00% Price (GBP)
580.00
Future deals are still on the cards, too, while currency-adjusted EPS for the year to 30 September 2019 is expected to grow somewhere between 4 per cent and 6 per cent on last year's 45.9¢ (34.9p).
IC View
Broker Peel Hunt's forecasts sit comfortably within the company’s guided 4 to 6 per cent EPS growth rate, even though 80 per cent of group operating profit is on track to grow at double-digit rates. While acquisitions are certainly driving a portion of that growth, investors would do well not to ignore underlying progress, either. At 609p, we remain buyers.
Last IC View: Buy, 582p, 27 Nov 2018